Ilian Iliev is the chief executive of NetScientific, an AIM-listed investor that specialises in helping its medtech, therapeutics, sustainability and robotics portfolio grow in three key markets: the US, the UK and Israel.

Ilian, who came to NetScientific after the firm acquired his VC EMV Capital, also tells us how that merger came to be, how the combined group isn’t afraid of acquiring startups to help turn them around before seeking external funding once more, and why the financial regulations around being a publicly traded company are a positive.

He also ponders how living through the fall of communism and then South African apartheid has shaped his views, and how his education at Cambridge convinced him that investing in a local fund, Martlet Capital, made sense.

Follow Thierry Heles on LinkedIn.

“Funky Chunk” Kevin MacLeod (incompetech.com)